Systems biology approaches to new vaccine development

Ann L Oberg, Richard B Kennedy, Peter Li, Inna G. Ovsyannikova, Gregory A. Poland

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The current 'isolate, inactivate, inject' vaccine development strategy has served the field of vaccinology well, and such empirical vaccine candidate development has even led to the eradication of smallpox. However, such an approach suffers from limitations, and as an empirical approach, does not fully utilize our knowledge of immunology and genetics. A more complete understanding of the biological processes culminating in disease resistance is needed. The advent of high-dimensional assay technology and 'systems biology' along with a vaccinomics approach [1,2] is spawning a new era in the science of vaccine development. Here we review recent developments in systems biology and strategies for applying this approach and its resulting data to expand our knowledge base and drive directed development of new vaccines. We also provide applied examples and point out new directions for the field in order to illustrate the power of systems biology.

Original languageEnglish (US)
Pages (from-to)436-443
Number of pages8
JournalCurrent Opinion in Immunology
Volume23
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Systems Biology
Vaccines
Biological Phenomena
Disease Resistance
Smallpox
Knowledge Bases
Allergy and Immunology
Technology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Systems biology approaches to new vaccine development. / Oberg, Ann L; Kennedy, Richard B; Li, Peter; Ovsyannikova, Inna G.; Poland, Gregory A.

In: Current Opinion in Immunology, Vol. 23, No. 3, 06.2011, p. 436-443.

Research output: Contribution to journalArticle

Oberg, Ann L ; Kennedy, Richard B ; Li, Peter ; Ovsyannikova, Inna G. ; Poland, Gregory A. / Systems biology approaches to new vaccine development. In: Current Opinion in Immunology. 2011 ; Vol. 23, No. 3. pp. 436-443.
@article{03f75f0fd07f4cc59c0d15fb67fe031f,
title = "Systems biology approaches to new vaccine development",
abstract = "The current 'isolate, inactivate, inject' vaccine development strategy has served the field of vaccinology well, and such empirical vaccine candidate development has even led to the eradication of smallpox. However, such an approach suffers from limitations, and as an empirical approach, does not fully utilize our knowledge of immunology and genetics. A more complete understanding of the biological processes culminating in disease resistance is needed. The advent of high-dimensional assay technology and 'systems biology' along with a vaccinomics approach [1,2•] is spawning a new era in the science of vaccine development. Here we review recent developments in systems biology and strategies for applying this approach and its resulting data to expand our knowledge base and drive directed development of new vaccines. We also provide applied examples and point out new directions for the field in order to illustrate the power of systems biology.",
author = "Oberg, {Ann L} and Kennedy, {Richard B} and Peter Li and Ovsyannikova, {Inna G.} and Poland, {Gregory A.}",
year = "2011",
month = "6",
doi = "10.1016/j.coi.2011.04.005",
language = "English (US)",
volume = "23",
pages = "436--443",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Systems biology approaches to new vaccine development

AU - Oberg, Ann L

AU - Kennedy, Richard B

AU - Li, Peter

AU - Ovsyannikova, Inna G.

AU - Poland, Gregory A.

PY - 2011/6

Y1 - 2011/6

N2 - The current 'isolate, inactivate, inject' vaccine development strategy has served the field of vaccinology well, and such empirical vaccine candidate development has even led to the eradication of smallpox. However, such an approach suffers from limitations, and as an empirical approach, does not fully utilize our knowledge of immunology and genetics. A more complete understanding of the biological processes culminating in disease resistance is needed. The advent of high-dimensional assay technology and 'systems biology' along with a vaccinomics approach [1,2•] is spawning a new era in the science of vaccine development. Here we review recent developments in systems biology and strategies for applying this approach and its resulting data to expand our knowledge base and drive directed development of new vaccines. We also provide applied examples and point out new directions for the field in order to illustrate the power of systems biology.

AB - The current 'isolate, inactivate, inject' vaccine development strategy has served the field of vaccinology well, and such empirical vaccine candidate development has even led to the eradication of smallpox. However, such an approach suffers from limitations, and as an empirical approach, does not fully utilize our knowledge of immunology and genetics. A more complete understanding of the biological processes culminating in disease resistance is needed. The advent of high-dimensional assay technology and 'systems biology' along with a vaccinomics approach [1,2•] is spawning a new era in the science of vaccine development. Here we review recent developments in systems biology and strategies for applying this approach and its resulting data to expand our knowledge base and drive directed development of new vaccines. We also provide applied examples and point out new directions for the field in order to illustrate the power of systems biology.

UR - http://www.scopus.com/inward/record.url?scp=79957777939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957777939&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2011.04.005

DO - 10.1016/j.coi.2011.04.005

M3 - Article

VL - 23

SP - 436

EP - 443

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 3

ER -